Published in Brain on May 01, 2001
Pathophysiology of parkinsonism. Clin Neurophysiol (2008) 1.71
Human category learning 2.0. Ann N Y Acad Sci (2010) 1.64
Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain (2006) 1.51
Conditional routing of information to the cortex: a model of the basal ganglia's role in cognitive coordination. Psychol Rev (2010) 1.51
Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Nutr Neurosci (2010) 1.51
The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology (2010) 1.18
The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev (2007) 1.15
Interactions between declarative and procedural-learning categorization systems. Neurobiol Learn Mem (2010) 1.09
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry (2005) 1.05
Early Parkinson's disease: longitudinal changes in brain activity during sequence learning. Neurobiol Dis (2009) 1.00
Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance. Proc Natl Acad Sci U S A (2014) 0.98
The caudate: a key node in the neuronal network imbalance of insomnia? Brain (2013) 0.98
Procedural learning deficits in specific language impairment (SLI): a meta-analysis of serial reaction time task performance. Cortex (2013) 0.96
A compensatory role for declarative memory in neurodevelopmental disorders. Neurosci Biobehav Rev (2015) 0.96
Fronto-striatal deficit in Parkinson's disease during semantic event sequencing. Neurobiol Aging (2006) 0.96
Neuroimaging in Parkinson's disease. Neurotherapeutics (2011) 0.95
Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits. Front Syst Neurosci (2014) 0.94
Reward-related learning via multiple memory systems. Biol Psychiatry (2012) 0.94
Effects of acute tryptophan depletion on executive function in healthy male volunteers. BMC Psychiatry (2003) 0.89
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Eur J Nucl Med Mol Imaging (2007) 0.89
Independent component analysis of the effect of L-dopa on fMRI of language processing. PLoS One (2010) 0.87
L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network. PLoS One (2009) 0.86
Frontostriatal and mediotemporal lobe contributions to implicit higher-order spatial sequence learning declines in aging and Parkinson's disease. Behav Neurosci (2013) 0.86
Procedural learning is impaired in dyslexia: evidence from a meta-analysis of serial reaction time studies. Res Dev Disabil (2013) 0.84
Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism. Mol Neurodegener (2011) 0.83
Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study. PLoS One (2012) 0.82
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. PLoS One (2013) 0.81
Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease. J Neuropsychol (2013) 0.81
Diminished activation of motor working-memory networks in Parkinson's disease. PLoS One (2013) 0.81
Impaired verbal memory in Parkinson disease: relationship to prefrontal dysfunction and somatosensory discrimination. Behav Brain Funct (2009) 0.80
Frontostriatal cognitive staging in Parkinson's disease. Parkinsons Dis (2011) 0.79
Neuroimaging studies of striatum in cognition part II: Parkinson's disease. Front Syst Neurosci (2015) 0.79
The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease. Exp Brain Res (2012) 0.78
Role of basal ganglia circuits in resisting interference by distracters: a swLORETA study. PLoS One (2012) 0.77
Strategic cognitive sequencing: a computational cognitive neuroscience approach. Comput Intell Neurosci (2013) 0.76
Proof of principle: Transformation approach alters caudate nucleus volume and structure-function associations. Brain Imaging Behav (2015) 0.76
Deep brain stimulation of the subthalamic nucleus alters frontal activity during spatial working memory maintenance of patients with Parkinson's disease. Neurocase (2016) 0.75
Acute effects of cocaine and cannabis on reversal learning as a function of COMT and DRD2 genotype. Psychopharmacology (Berl) (2015) 0.75
Intact Acquisition and Short-Term Retention of Non-Motor Procedural Learning in Parkinson's Disease. PLoS One (2016) 0.75
An fMRI Study of the Impact of Block Building and Board Games on Spatial Ability. Front Psychol (2016) 0.75
Cognitive Function in Parkinson's Disease Patients with and without Anxiety. Neurol Res Int (2016) 0.75
Differential patterns of planning impairments in Parkinson's disease and sub-clinical signs of dementia? A latent-class model-based approach. PLoS One (2012) 0.75
Neuroimaging studies of the striatum in cognition Part I: healthy individuals. Front Syst Neurosci (2015) 0.75
Altered praxis network underlying limb kinetic apraxia in Parkinson's disease - an fMRI study. Neuroimage Clin (2017) 0.75
Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci (2000) 8.71
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology (2006) 4.06
In-vivo measurement of activated microglia in dementia. Lancet (2001) 3.51
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49
Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia (1994) 3.46
Evidence for striatal dopamine release during a video game. Nature (1998) 3.28
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci (1999) 3.06
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med (1992) 3.00
Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci (1999) 2.92
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol (1991) 2.84
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
Motor sequence learning: a study with positron emission tomography. J Neurosci (1994) 2.71
Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab (1996) 2.66
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry (2005) 2.54
Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci (2000) 2.47
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Anatomy of motor learning. I. Frontal cortex and attention to action. J Neurophysiol (1997) 2.29
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry (1998) 2.24
Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy. Lancet (1994) 2.17
Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain (1997) 2.15
A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc (1998) 2.13
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry (2008) 2.12
Anatomy of motor learning. II. Subcortical structures and learning by trial and error. J Neurophysiol (1997) 1.97
Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci (2000) 1.94
Relation between cerebral activity and force in the motor areas of the human brain. J Neurophysiol (1995) 1.91
Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology (2006) 1.88
An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain (1996) 1.87
Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol (1992) 1.86
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol (1999) 1.85
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain (2001) 1.83
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry (2005) 1.83
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77
Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain (2000) 1.75
Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res (1999) 1.72
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol (1996) 1.70
Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology (2009) 1.70
Neural systems engaged by planning: a PET study of the Tower of London task. Neuropsychologia (1996) 1.70
Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain (1997) 1.61
Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes (Lond) (2006) 1.61
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology (2003) 1.61
A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol (1993) 1.58
Cortical processing in persistent vegetative state. Wolfson Brain Imaging Centre Team. Lancet (1998) 1.58
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain (1997) 1.57
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. Brain (1999) 1.54
When thoughts become action: an fMRI paradigm to study volitional brain activity in non-communicative brain injured patients. Neuroimage (2007) 1.54
Dopamine agonists: their role in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2000) 1.48
Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study. Neurology (2000) 1.46
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology (1999) 1.46
Combined pedunculopontine-subthalamic stimulation in Parkinson disease. Neurology (2012) 1.45
Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol (1992) 1.43
L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles. Mov Disord (1995) 1.43
Transmodal sensorimotor networks during action observation in professional pianists. J Cogn Neurosci (2005) 1.42
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) (1992) 1.41
Clinical and [18F] dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry (1995) 1.39
Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults. Lancet (1999) 1.39
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol (1990) 1.39
Functional anatomy of visuomotor skill learning in human subjects examined with positron emission tomography. Eur J Neurosci (1996) 1.38
Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain (1999) 1.37
[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology (1999) 1.36
Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1997) 1.34
Preliminary report: activation of the cerebellum in essential tremor. Lancet (1990) 1.33
Identification of the cerebral loci processing human swallowing with H2(15)O PET activation. J Neurophysiol (1999) 1.33
Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain (1993) 1.31
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. J Neurol Neurosurg Psychiatry (2005) 1.29
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition. Brain (2008) 1.29
Brain mechanisms of successful compensation during learning in Alzheimer disease. Neurology (2006) 1.28
fMRI BOLD response to increasing task difficulty during successful paired associates learning. Neuroimage (2003) 1.27
Brain or vein--oxygenation or flow? On signal physiology in functional MRI of human brain activation. NMR Biomed (1994) 1.26
Motor reorganization in acquired hemidystonia. Ann Neurol (1995) 1.25
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain (2005) 1.24
Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology (1992) 1.24
Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain (1997) 1.24
Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann Neurol (1996) 1.23
A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol (1999) 1.23
Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol (1994) 1.23
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology (2003) 1.22
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1994) 1.21
Cognitive performance in multiple system atrophy. Brain (1992) 1.21
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain (1996) 1.21
Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain (2002) 1.20
Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse (1992) 1.20
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. Brain (1997) 1.19
Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET. J Neurophysiol (1998) 1.19
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology (2006) 1.18